PodManager™ Apk

PodManager™ Apk

Latest version 3.9
15 Nov 2024

Older Versions

Apk Infos

Version3.9
Rating5.0/5, based on 1 votes
Size‎63.5 MB
Requires AndroidAndroid 9.0.+ (Pie)
Author's NotesManage your treatment schedule seamlessly with the PodManager App

About PodManager™ APK

PodManager™ APK Download for Android
PodManager™ APK Download for Android

Description

Manage your treatment schedule seamlessly with the PodManager App

• Fully customizable reminders for your medications or activities help you adhere to your CF regimen.
•Treatment tracking function allows the user to record each time they have taken a dose, completed a treatment, or finished an activity
• Adherence data compiled and displayed in graphs, calendar, and reports
• Library of educational resources for TOBI Podhaler and access to patient support programs
• Real-time air quality alerts deliver a convenient update about the current outside environment based on the user’s location

INDICATION
TOBI Podhaler (Tobramycin Inhalation Powder) 28 mg per capsule is a prescription inhaled medication for cystic fibrosis patients whose lungs contain bacteria called Pseudomonas aeruginosa.

It is not known if TOBI Podhaler is safe and effective in patients under 6 years of age, in those with lung function outside of a certain range, or in those whose lungs contain bacteria called Burkholderia cepacia.

IMPORTANT SAFETY INFORMATION
Do not swallow TOBI Podhaler capsules. TOBI Podhaler capsules are used only with the Podhaler device and inhaled through your mouth (oral inhalation). Never place a capsule in the mouthpiece of the Podhaler device.

You should not use TOBI Podhaler if you are allergic to it or to any other aminoglycoside antibacterial medicines.

Tell your doctor before starting treatment all of your medical conditions, including if you have or have had hearing problems, dizziness, kidney problems, muscle weakness, breathing problems such as wheezing, coughing or chest tightness, if you had an organ transplant, are pregnant or nursing or plan to become pregnant or nurse.

TOBI Podhaler contains a medicine that can harm your unborn baby. It is not known if it passes into breast milk. Check your baby for watery stools, bloody stools, thrush or diaper rash if you breast feed.

Tell your doctor about all the medicines you take including over-the-counter medicines, vitamins, and herbal supplements. If you are using TOBI Podhaler, discuss if you should take other medicines that may harm your nervous system, kidneys, or hearing; "water pills" (diuretics) such as Edecrin® (ethacrynic acid), Lasix® (furosemide), or intravenous mannitol; urea.

TOBI Podhaler can cause serious side effects, including:
Severe breathing problems (bronchospasm). Tell your doctor right away if you get shortness of breath with wheezing or coughing and chest tightness while using TOBI Podhaler.

Hearing loss or ringing in the ears (ototoxicity). Tell your doctor right away if you have hearing loss, noises in your ears such as ringing or hissing, vertigo, difficulty with balance, or dizziness.

Worsening kidney problems (nephrotoxicity). TOBI Podhaler is in a class of medicines that may cause worsening kidney problems, especially in people with known or suspected kidney problems. Your healthcare provider may do a blood test to check how your kidneys are working while you are using TOBI Podhaler.

Worsening muscle weakness. TOBI Podhaler is in a class of medicines that can cause worsening muscle weakness in people who already have problems with muscle weakness (myasthenia gravis or Parkinson's disease).

The most common side effects of TOBI Podhaler include cough, worsening of lung problems or cystic fibrosis, productive cough, shortness of breath, fever, sore throat, changes in your voice (hoarseness), coughing up blood, and headache.

Let your doctor know if your symptoms worsen or if you have a side effect that bothers you enough to stop treatment or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information and Patient Information on Tobipodhaler.com

© 2021 Viatris Inc. All rights reserved. TOBI-2020-0239

How to install PodManager™ APK on Android phone or tablet?

Download PodManager™ APK file from ApkClean, then follow these steps:

Update Phone Settings

  • Go to your phone Settings page
  • Tap Security or Applications (varies with device)
  • Check the Unknown Sources box
  • Confirm with OK

Go to Downloads

  • Open Downloads on your device by going to My Files or Files
  • Tap the APK file you downloaded (com.mylan.tobi-v3.9-ApkClean.apk)
  • Tap Install when prompted, the APK file you downloaded will be installed on your device.

Older Versions

3.9 (105)63.5 MB
3.6 (103)63.3 MB

Questions & Answers

Q: What is an APK File?

A: Just like Windows (PC) systems use an .exe file for installing software, Android does the same. An APK file is the file format used for installing software on the Android operating system.

Q: If I install an APK from this website, will I be able to update the app from the Play Store?

A: Yes, absolutely. The Play Store installs APKs it downloads from Google's servers, and sideloading from a site like ApkClean.net goes through a very similar process, except you're the one performing the downloading and initiating the installation (sideloading).
As soon as the Play Store finds a version of the app newer than the one you've sideloaded, it will commence an update.

Q: Why ApkClean.net can guarantee APK 100% safe?

A: Whenever someone wants to download an APK file from ApkClean.net, we'll check the corresponding APK file on Google Play and allow user download it directly (of course, we'll cache it on our server). If the APK file does not exist on Google Play, we'll search it in our cache.

Q: What are Android App permissions?

A: Apps require access to certain systems within your device. When you install an application, you are notified of all of the permissions required to run that application.

Don't hesitate to contact us if you have any questions or concerns.

(*) is required